Fulgent Genetics Income Statement (2015-2026) | FLGT

Income Statement Mar2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
227.87M251.67M320.27M125.34M105.66M83.60M66.17M67.85M84.69M70.50M64.48M71.03M71.74M76.21M73.46M81.80M84.07M0.40M71.14M85.39M
Cost of Revenue (Quarter)
43.47M62.13M77.72M60.06M59.56M54.72M47.36M47.28M44.84M45.28M42.38M44.54M44.97M44.37M45.12M47.37M48.56M50.75M49.65M59.71M
Gross Profit (Quarter)
184.40M189.54M242.54M65.28M46.09M12.99M18.81M20.57M39.84M25.23M22.10M26.49M26.77M31.85M28.35M34.44M35.51M32.58M21.49M25.68M
Operating items
Amortization - Intangibles (Quarter)
0.80M0.91M0.91M1.57M2.01M2.01M1.97M1.96M1.96M1.91M2.00M2.00M1.99M1.97M2.00M1.99M2.00M2.03M2.03M2.60M
Research & Development (Quarter)
6.01M8.20M5.99M10.87M7.51M10.25M10.08M10.72M10.01M11.98M8.99M13.49M11.78M12.11M8.46M13.48M13.86M3.64M12.22M15.23M
Selling, General & Administrative (Quarter)
12.30M22.10M25.77M30.24M26.27M28.79M21.80M17.99M17.50M31.71M21.49M21.33M20.95M24.34M25.29M26.39M23.34M41.65M27.68M27.20M
Restructuring Costs (Quarter)
0.10M1.50M2.60M0.30M
Other Operating Expenses (Quarter)
6.82M8.38M8.85M11.38M11.97M10.49M11.75M11.65M12.12M132.66M13.42M10.59M11.12M11.53M14.38M14.28M13.57M22.04M13.61M19.03M
Operating Expenses (Quarter)
25.13M38.68M40.61M52.48M45.74M49.54M43.63M40.37M39.63M176.35M43.90M45.40M43.85M47.98M48.14M54.15M50.86M68.82M56.11M61.75M
Operating Income (Quarter)
159.27M150.86M201.93M12.79M0.35M17.00M-24.82M-19.80M0.21M-151.12M-21.80M-18.91M-17.08M-16.14M-19.80M-19.71M-15.35M-0.50M-34.62M-36.07M
EBIT (Quarter)
159.27M150.86M201.93M12.79M0.35M17.00M-24.82M-19.80M0.21M-151.12M-21.80M-18.91M-17.08M-16.14M-19.80M-19.71M-15.35M-0.50M-34.62M-36.07M
Non-operating items
Interest & Investment Income (Quarter)
0.50M-0.04M0.04M0.96M1.41M3.22M3.77M5.10M6.47M5.81M7.38M7.71M8.09M8.12M8.02M8.09M7.87M6.94M8.65M6.40M
Other Non Operating Income (Quarter)
0.24M-0.02M-0.01M0.01M0.54M0.01M0.07M0.05M-0.01M0.04M0.01M0.04M
Non Operating Income (Quarter)
6.65M5.92M7.62M7.69M-1.45M8.09M8.07M-1.81M7.84M6.96M8.64M6.38M
Net income details
EBT (Quarter)
159.77M150.82M201.98M13.75M1.76M-33.46M-21.05M-14.70M6.86M2.27M-14.17M-11.21M-18.53M-2.90M-11.72M-21.52M-7.51M-21.01M-25.98M-29.69M
Tax Provisions (Quarter)
37.55M47.15M48.40M2.65M0.41M-9.39M-5.20M-3.10M20.33M-22.31M-0.30M-2.12M-3.84M1.90M0.20M-2.26M-0.70M5.90M-0.70M0.03M
Profit After Tax (Quarter)
122.22M104.34M153.56M11.10M1.34M-24.08M-15.85M-11.59M-13.11M-135.56M-13.85M-9.09M-14.65M-5.89M-11.90M-19.26M-6.83M-23.65M-24.51M-29.72M
Equity Income (Quarter)
Income from Non-Controlling Interests (Quarter)
-0.30M-0.66M-0.42M-0.44M-0.38M-0.24M-0.51M-0.36M-0.36M-6.18M-0.38M-0.38M-0.05M-0.30M-0.37M-0.30M-0.22M-0.23M-0.45M-0.19M
Income from Continuing Operations (Quarter)
122.22M103.68M153.58M11.10M1.34M-24.08M-15.85M-11.60M-13.47M24.58M-13.87M-9.09M-14.69M-4.80M-11.92M-19.26M-6.81M-26.91M-25.28M-29.72M
Consolidated Net Income (Quarter)
122.22M103.68M153.58M11.10M1.34M-24.08M-15.85M-11.60M-13.47M24.58M-13.87M-9.09M-14.69M-4.80M-11.92M-19.26M-6.81M-26.91M-25.28M-29.72M
Income towards Parent Company (Quarter)
122.22M103.68M153.58M11.10M1.34M-24.08M-15.85M-11.60M-13.47M24.58M-13.87M-9.09M-14.69M-4.80M-11.92M-19.26M-6.81M-26.91M-25.28M-29.72M
Net Income towards Common Stockholders (Quarter)
122.22M103.68M153.58M11.10M1.34M-24.08M-15.34M-11.23M-13.11M-128.15M-13.46M-8.71M-14.65M-5.89M-11.53M-18.96M-6.61M-23.42M-24.83M-29.53M
Additional items
EPS (Basic) (Quarter)
4.123.535.080.370.04-0.80-0.52-0.38-0.44-4.30-0.45-0.29-0.48-0.19-0.37-0.62-0.21-0.76-0.80-1.05
EPS (Diluted) (Quarter)
3.923.354.920.360.04-0.78-0.52-0.38-0.44-4.30-0.45-0.29-0.48-0.19-0.37-0.62-0.21-0.76-0.80-1.05
Shares Outstanding (Quarter)
29.67M29.41M30.23M30.36M30.17M30.10M29.54M29.81M30.01M29.78M29.77M30.10M30.42M30.23M30.83M30.54M30.75M30.78M30.88M28.00M
Shares Outstanding (Diluted) (Quarter)
31.17M30.98M31.24M31.19M30.87M30.96M29.54M29.81M30.01M29.78M29.77M30.10M30.42M30.23M30.83M30.54M30.75M30.78M30.88M28.00M
Shares Outstanding (Entity) (Quarter)
29.83M30.16M30.33M30.48M30.68M31.25M31.50M31.73M31.93M29.65M29.89M30.26M30.54M30.84M30.62M30.61M30.85M31.08M28.85M28.00M
EBITDA (Quarter)
159.27M150.86M201.93M12.79M0.35M17.00M-24.82M-19.80M0.21M-151.12M-21.80M-18.91M-17.08M-16.14M-19.80M-19.71M-15.35M-0.50M-34.62M-36.07M
Interest Expenses (Quarter)
18.11M0.09M15.18M7.53M7.54M0.83M2.67M15.71M40.42M-0.45M0.44M10.91M1.24M0.04M0.06M0.55M0.01M0.02M1.52M8.88M
Tax Rate (Quarter)
23.50%31.26%23.96%19.29%23.56%28.05%24.70%21.09%296.30%-983.77%2.12%18.94%20.71%-65.47%-1.71%10.52%9.32%-28.10%2.69%-0.10%